EP1611160A2 - Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus; - Google Patents
Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus;Info
- Publication number
- EP1611160A2 EP1611160A2 EP04742458A EP04742458A EP1611160A2 EP 1611160 A2 EP1611160 A2 EP 1611160A2 EP 04742458 A EP04742458 A EP 04742458A EP 04742458 A EP04742458 A EP 04742458A EP 1611160 A2 EP1611160 A2 EP 1611160A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- advantageously
- polymer
- molecular weight
- crosslinking
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/738—Cross-linked polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Definitions
- Crosslinking of low and high molecular weight polysaccharides preparation of injectable monophasic hydroqels; polysaccharides and hydro ⁇ els obtained.
- the subject of the present invention is:
- hydrogels in question based on said crosslinked polymers, have numerous outlets, in particular as filling material in restorative, aesthetic, dental surgeries, in ophthalmology, in orthopedics ... as a product preventing tissue adhesions, in general surgery, urology ... Said hydrogels are particularly suitable for repairing the vocal cords.
- outlets indicated above, in a nonlimiting manner, for this type of product, are familiar to those skilled in the art.
- the invention results from a real effort to optimize the implementation of the crosslinking of the polymers in question, with a view to obtaining injectable monophasic hydrogels, which are particularly advantageous with reference to the compromise below: mechanical properties and persistence, on the one hand, injectability (with injection forces and acceptable injection needle diameters), on the other hand.
- the injectable qualifier used in the present text means manually injectable by means of syringes fitted with conventional needles (of a diameter between 0.1 and 0.5 mm).
- hydrogels injectable through hypodermic needles of 30 G 1. , 27 G 1 /., 26 G 1 /., 25 G.
- compositions With reference to the specific problem of injectability, two-phase compositions have been proposed, the continuous phase of which in particular is based on such hydrogels. Said continuous phase serves as a plasticizer, as an injection vehicle for a dispersed phase. This dispersed phase is more or less solid, more or less differentiated from the continuous phase. So :
- the biphasic compositions described consist of two phases - continuous, dispersed - bioresorbable and are in the form of sludge. Said two phases are advantageously prepared from Hylan fibers (natural hyaluronic acid chemically modified in situ in order to facilitate its extraction from the tissues), - in application WO-A-96 337 51, the biphasic compositions described also have two bioresorbable phases, better separated, the dispersed phase consisting of insoluble fragments of a polymer hydrogel (chosen from hyaluronic acid and its salts), highly crosslinked; - In application WO-A-00 014 28, the biphasic compositions described contain a dispersed phase, not bioresorbable (particles of at least one hydrogel of a (co) polymer obtained by polymerization and crosslinking of acrylic acid and / or methacrylic acid and / or at least one derivative of said acids), in suspension in an aqueous solution
- the product in question is not an injectable hydrogel but a product of solid consistency.
- eye implants are in fact described, used to temporarily fill a vacuum created surgically.
- the hydrogel produced is proposed as a substitute for the vitreous body.
- the polymer in question sodium hyaluronate
- the monophasic hydrogel described is charged with an antiseptic, effective to protect it, after implantation, against free radicals.
- WO-A-02 063 50 a process is described, capable of generating this type of hydrogel, very homogeneous in its mass.
- All these monophasic hydrogels were obtained from polymers of high molecular mass, crosslinked with the intervention of an effective and not excessive amount of at least one crosslinking agent, in aqueous solvent.
- the inventors wished to improve the efficiency of the crosslinking of the polymer in question so as in particular to improve the resistance to degradation (the persistence) of the implanted hydrogel, while retaining the possibility of injecting said hydrogel under acceptable conditions.
- the inventors first thought of involving more crosslinking agent. This approach was quickly discarded insofar as it inevitably leads to denaturation of the polymer in question and chemical pollution of the crosslinked product obtained. Said inventors then thought of increasing the concentration of polymer in the reaction mixture.
- the inventors have surprisingly established that by combining low molecular weight polymer (s) and high molecular weight polymer (s), an excellent compromise is obtained, namely the possibility of generating, for a non-excessive crosslinking rate (equivalent to that of the prior art) a monophasic, injectable hydrogel with improved mechanical properties and remanence.
- This low mass / high mass association makes it possible to obtain a hydrogel which more than satisfactorily meets the following specifications: - monophasic,
- the key factor of the crosslinking process of the invention therefore resides in the concentration of the reagents (which is increased compared to that of the reaction mixtures of the prior art, due to the intervention of low molecular weight polymer (s). ), the crosslinking of said concentrated reagents being however "controlled” by the intervention of polymer (s) of high molecular weight, which guarantee the homogeneity of the crosslinked product and then of the hydrogel obtained.
- the present invention therefore relates to a process for crosslinking at least one polymer chosen from polysaccharides and their derivatives, used in aqueous solvent by action of an effective and not excessive amount of at least one crosslinking agent, improved in that it is used on a mixture containing at least one low molecular weight polymer and at least one high molecular weight polymer.
- Said mixture naturally includes the said (s) polymer (s) of low molecular weight in sufficient quantity to guarantee a relatively high concentration of the reaction medium in polymer (s) and the said (s) polymer (s) ) of high molecular mass in an amount sufficient to guarantee a homogeneous consistency to said crosslinked polymer obtained.
- the crosslinking method of the invention is a method of crosslinking polymers chosen from polysaccharides and their derivatives.
- the polymer (s) in question can therefore not be natural or synthetic.
- natural polymers are hyaluronic acid and its salts, other glycosaminoglycans, such as chondroitin sulfates, keratan sulfate, heparin, heparan sulfate, alginic acid and its biologically acceptable salts, starch, amylose, dextran, xanthan, pullulan ...
- Examples of synthetic derivatives of natural polysaccharides are carboxyoixose, carboxymethylcellutose, alkylcelluloses, such as hydroxyethylcellulose, hydroxypropylmethylcellulose (HPMC) , oxidized starch ...
- the process of the invention is likely to be suitable for the crosslinking of any one of these polymers, insofar as said polymer intervenes at low (s) and high (s) molecular weights.
- the process of the invention is likely to be suitable for the crosslinking of mixtures of such polymers, said mixtures containing at least one low molecular weight polymer and at least one high molecular weight mixture.
- the reaction medium contains a single polymer, which is involved in at least two differentiated molecular weights: at least one weak and at least one strong.
- the same polymer is preferably used at a single low molecular weight and at a single high molecular weight.
- the polymer in question is advantageously a salt of hyaluronic acid. It is very advantageously chosen from the sodium salt, the potassium salt and their mixtures. It preferably consists of the sodium salt (NaHA).
- crosslinking of this type of polymer a person skilled in the art understands that said crosslinking is carried out in a basic aqueous solvent. In general, said crosslinking is obviously carried out under pH conditions favorable to the dissolution of the polymer in question.
- reaction mixture contains:
- said reaction mixture advantageously has an intrinsic viscosity of less than 1,900 ml / g, ie
- the reaction mixture advantageously contains more than 50%, very advantageously more than 70%, by mass of at least one salt of hyaluronic acid of low molecular mass m and therefore, logically, advantageously less than 50%, very advantageously less than 30%, by mass of at least one salt of hyaluronic acid of high molecular mass M.
- crosslinking method of the invention is advantageously implemented with the sodium salt of hyaluronic acid, intervening at a low molecular mass m and at a high molecular mass M. We then very advantageously have: m ⁇ 3.10 5 Da and M ⁇ 3.10 6 Da.
- crosslinking agent with all types of polymer, any agent known to crosslink polysaccharides and their derivatives can be used, via its hydroxyl functions - crosslinking agent at least bifunctional, to ensure crosslinking - and in particular an epoxy or its derivatives. We recommend the intervention of crosslinking agents, bifunctional, alone or in mixture.
- crosslinking agent s
- ⁇ crosslinking rate
- ⁇ _ Total number of reactive functions of said crosslinking agent ⁇ ⁇ QQ Total number of disaccharide units of the polymer molecules between 0.5 and 70%, advantageously between 4 and 50%.
- crosslinking process of the invention is original due to the forms of intervention of the polymers in question. Otherwise, it is implemented in a conventional manner with at least one crosslinking agent. It is noted that said crosslinking agent is generally reacted on the dissolved polymer (s). It is however in no way excluded that it intervenes on the said polymer (s) during hydration, according to the process described in WO-A-02 06 350.
- the crosslink obtained at the end of the implementation of the crosslinking process of the invention is generally formulated to generate the desired injectable monophasic hydrogel. It is if necessary neutralized beforehand.
- the formulation is implemented in a buffered solution at a pH compatible with the human body (since the hydrogel in question is generally intended for injection into the human body): pH between 6.5 and 7.5 advantageously between 7 and 7.4, very advantageously between 7.1 and 7.3.
- the crosslinked polymer equilibrates. It also acquires an osmolarity compatible with that of the human body ...
- the crosslinked polymers of the invention diluted are monophasic hydrogels.
- an injectable hydrogel of the invention is prepared, by crosslinking a mixture of at least one polymer, salt (s) of hyaluronic acid (see above), by neutralizing the reticulate obtained, then by formulating it in a buffered solution at a pH between 7.1 and 7.3, at a concentration between 10 and 40 mg / g, advantageously between 20 and 30 mg / g.
- the process for preparing the injectable monophasic hydrogel from the crosslinked polymer constitutes the second object of the present invention.
- third and fourth objects consist respectively of the crosslinked polymer capable of being obtained after the implementation of the crosslinking process (first object) and the injectable monophasic hydrogel capable of being obtained by formulation. (second object) of said crosslinked polymer, as specified above.
- Said polymer and hydrogel advantageously contain low molecular weight sodium hyaluronate and high molecular weight sodium hyaluronate; said low molecular weight sodium hyaluronate very advantageously occurring at more than 50% by mass.
- the structure of the injectable monophasic hydrogel - fourth object of the present invention - is original. Its consistency resists degradation. This resistance of the hydrogel is much higher than that of equivalent products of the prior art.
- hydrogels of the invention have the outlets indicated in the introduction to this text. They are particularly effective there. It is now proposed to illustrate the invention in its various aspects, by the examples below. More precisely, we have:
- Example 1 which illustrates the prior art (crosslinking of a high molecular weight polymer)
- Example 2 which illustrates the remarks made in the introduction to this text (crosslinking of the same low molecular weight polymer)
- the intrinsic viscosity of sodium hyaluronate (NaHA) (in ml / g) is determined in accordance with the European Pharmacopoeia of NaHA (2.2.9), by a capillary viscometer of Ubelhode type.
- the injectability of the NaHA-based gel is determined by measuring the force required (in Newton, N) to eject the gel contained in a standard syringe, through a 27 GVz needle, at a speed of 12.5 mm / min. The tests were carried out on a Verstatet ® traction device sold by the company Mecmésin.
- the consistency of the gel is characterized at 25 ° C. by a rheological measurement of the elastic (G 1 ) and viscous (G ") modules as a function of the frequency (from 0.05 to 10 Hz) and in the fields of constant deformation, at using a constrained constraint rheometer (Carrimed CSL 500 from TA Instruments) and a cone / plane geometry 4 cm 2 ° This rheometer is checked and calibrated regularly
- the gels are degraded by being brought to the temperature of 93 °. vs.
- Macroscopic aspect flexible and continuous
- Macroscopic aspect "puree" which fragments very easily - no cohesion of the gel nor of shooting aspect.
- NaHA sodium hyaluronate fibers
- the reaction lasts 2 h.
- [NaHA] f NaHA concentration in the final hydrogel after reaction and dilution with a quantity qs of phosphate buffer
- hydrogels of the invention (examples 3 and 4) have a rheological behavior different from that of the hydrogel of the prior art (example 1).
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20100181594 EP2289945B1 (fr) | 2003-04-10 | 2004-04-08 | Réticulation de hyaluronates de sodium de faible et forte masse moléculaire; préparation d'hydrogels monophasiques injectables; hyaluronate de sodium rétioculé et hydrogel ainsi obtenus |
EP20140200048 EP2868669A1 (fr) | 2003-04-10 | 2004-04-08 | Hyaluronate de sodium se présentant sous la forme de deux masses moléculaires différenciées réticulé et hydrogel monophasique injectable le contenant |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0304444A FR2861734B1 (fr) | 2003-04-10 | 2003-04-10 | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
PCT/FR2004/000870 WO2004092222A2 (fr) | 2003-04-10 | 2004-04-08 | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus; |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20140200048 Division EP2868669A1 (fr) | 2003-04-10 | 2004-04-08 | Hyaluronate de sodium se présentant sous la forme de deux masses moléculaires différenciées réticulé et hydrogel monophasique injectable le contenant |
EP20100181594 Division EP2289945B1 (fr) | 2003-04-10 | 2004-04-08 | Réticulation de hyaluronates de sodium de faible et forte masse moléculaire; préparation d'hydrogels monophasiques injectables; hyaluronate de sodium rétioculé et hydrogel ainsi obtenus |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1611160A2 true EP1611160A2 (fr) | 2006-01-04 |
Family
ID=33186443
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04742458A Ceased EP1611160A2 (fr) | 2003-04-10 | 2004-04-08 | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus; |
EP20140200048 Withdrawn EP2868669A1 (fr) | 2003-04-10 | 2004-04-08 | Hyaluronate de sodium se présentant sous la forme de deux masses moléculaires différenciées réticulé et hydrogel monophasique injectable le contenant |
EP20100181594 Revoked EP2289945B1 (fr) | 2003-04-10 | 2004-04-08 | Réticulation de hyaluronates de sodium de faible et forte masse moléculaire; préparation d'hydrogels monophasiques injectables; hyaluronate de sodium rétioculé et hydrogel ainsi obtenus |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20140200048 Withdrawn EP2868669A1 (fr) | 2003-04-10 | 2004-04-08 | Hyaluronate de sodium se présentant sous la forme de deux masses moléculaires différenciées réticulé et hydrogel monophasique injectable le contenant |
EP20100181594 Revoked EP2289945B1 (fr) | 2003-04-10 | 2004-04-08 | Réticulation de hyaluronates de sodium de faible et forte masse moléculaire; préparation d'hydrogels monophasiques injectables; hyaluronate de sodium rétioculé et hydrogel ainsi obtenus |
Country Status (8)
Country | Link |
---|---|
US (9) | US7741476B2 (fr) |
EP (3) | EP1611160A2 (fr) |
JP (1) | JP4827727B2 (fr) |
BR (1) | BRPI0409762B1 (fr) |
CA (1) | CA2521961C (fr) |
ES (1) | ES2536564T3 (fr) |
FR (1) | FR2861734B1 (fr) |
WO (1) | WO2004092222A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9144631B2 (en) | 2003-01-27 | 2015-09-29 | Benedicte Asius | Ceramic-based injectable implants which are used to fill wrinkles, cutaneous depressions and scars, and preparation method thereof |
Families Citing this family (144)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7338433B2 (en) | 2002-08-13 | 2008-03-04 | Allergan, Inc. | Remotely adjustable gastric banding method |
EP1553878B1 (fr) | 2002-08-28 | 2010-02-24 | Allergan, Inc. | Dispositif de cerclage gastrique resistant a l'usure |
FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
US8524213B2 (en) | 2003-12-30 | 2013-09-03 | Genzyme Corporation | Polymeric materials, their preparation and use |
KR101291439B1 (ko) * | 2004-01-23 | 2013-07-31 | 알러간, 인코포레이티드 | 해제가능하게 고정할 수 있는 일체형의 조절가능한 위밴드 |
BRPI0508527A (pt) | 2004-03-08 | 2007-08-14 | Endoart Sa | sistema de fechamento para órgãos tubulares |
EP1732635B1 (fr) | 2004-03-18 | 2011-07-27 | Allergan, Inc. | Appareil de reglage du volume de ballons intragastriques |
US20050281880A1 (en) * | 2004-05-20 | 2005-12-22 | Wei Wang | Methods for making injectable polymer hydrogels |
ITTO20040918A1 (it) * | 2004-12-29 | 2005-03-29 | Luigi Ambrosio | Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione |
GB2423252B (en) * | 2005-02-18 | 2007-10-17 | Engelhard Lyon | Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols |
FR2882366B1 (fr) | 2005-02-18 | 2008-04-18 | Coletica Sa | Polymere reticule de carbohydrate, notamment a base de polysaccharides et/ou de polyols |
US8251888B2 (en) | 2005-04-13 | 2012-08-28 | Mitchell Steven Roslin | Artificial gastric valve |
US8043206B2 (en) | 2006-01-04 | 2011-10-25 | Allergan, Inc. | Self-regulating gastric band with pressure data processing |
US7798954B2 (en) | 2006-01-04 | 2010-09-21 | Allergan, Inc. | Hydraulic gastric band with collapsible reservoir |
PL2026821T3 (pl) * | 2006-05-11 | 2010-03-31 | Sandra Gobbo | Binarne mieszaniny kwasu hialuronowego i ich zastosowanie terapeutyczne |
FR2909560B1 (fr) * | 2006-12-06 | 2012-12-28 | Fabre Pierre Dermo Cosmetique | Gel d'acide hyaluronique pour injection intradermique |
BRPI0811784A2 (pt) * | 2007-05-23 | 2011-05-10 | Allergan Inc | colÁgeno reticulado e uso do mesmo |
US20110077737A1 (en) * | 2007-07-30 | 2011-03-31 | Allergan, Inc. | Tunably Crosslinked Polysaccharide Compositions |
US20120071437A1 (en) | 2007-07-30 | 2012-03-22 | Allergan, Inc. | Tunable crosslinked polysaccharide compositions |
US8318695B2 (en) * | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
US8697044B2 (en) * | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
EP2207424B1 (fr) | 2007-11-16 | 2014-06-04 | Allergan, Inc. | Compositions et procédés de traitement du purpura |
US8394784B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
US20090143348A1 (en) * | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
US8394782B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
FR2924615B1 (fr) | 2007-12-07 | 2010-01-22 | Vivacy Lab | Hydrogel cohesif biodegradable. |
WO2009082354A1 (fr) * | 2007-12-21 | 2009-07-02 | Encecor Ab | Hydrogel réticulé contenant une substance active |
US8668863B2 (en) * | 2008-02-26 | 2014-03-11 | Board Of Regents, The University Of Texas System | Dendritic macroporous hydrogels prepared by crystal templating |
JP5574083B2 (ja) * | 2008-08-01 | 2014-08-20 | アンタイス エス.エイ. | 高い残留性及び容量を与える高い能力を有する注入可能なヒドロゲル |
US20130102563A1 (en) * | 2008-08-04 | 2013-04-25 | Allergan, Inc. | Dermal filler with lidocaine |
US8357795B2 (en) * | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
AU2015252122A1 (en) * | 2008-08-04 | 2015-11-26 | Allergan Industrie Sas | Hyaluronic acid-based gels including anesthetic agents |
ES2829971T3 (es) * | 2008-09-02 | 2021-06-02 | Tautona Group Lp | Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos |
EP2341953B1 (fr) | 2008-09-04 | 2018-11-21 | The General Hospital Corporation | Hydrogels pour l'augmentation et la réparation des cordes vocales et de tissu mou |
US20100305397A1 (en) * | 2008-10-06 | 2010-12-02 | Allergan Medical Sarl | Hydraulic-mechanical gastric band |
WO2010042493A1 (fr) | 2008-10-06 | 2010-04-15 | Allergan, Inc. | Bande gastrique mécanique avec coussins |
US20100185049A1 (en) | 2008-10-22 | 2010-07-22 | Allergan, Inc. | Dome and screw valves for remotely adjustable gastric banding systems |
FR2938187B1 (fr) | 2008-11-07 | 2012-08-17 | Anteis Sa | Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur |
JP4885245B2 (ja) * | 2009-01-15 | 2012-02-29 | 日本航空電子工業株式会社 | Rdコンバータ及び角度検出装置 |
NO2236523T3 (fr) | 2009-03-30 | 2018-07-21 | ||
ES2621380T3 (es) * | 2009-04-02 | 2017-07-03 | Allergan, Inc. | Hidrogeles con forma de cabello para aumento de tejidos blandos |
US20100261893A1 (en) * | 2009-04-09 | 2010-10-14 | Scivision Biotech Inc. | Method for producing cross-linked hyaluronic acid |
US9371402B2 (en) | 2009-04-09 | 2016-06-21 | Scivision Biotech Inc. | Method for producing cross-linked hyaluronic acid |
US8390326B2 (en) * | 2009-05-05 | 2013-03-05 | William Marsh Rice University | Method for fabrication of a semiconductor element and structure thereof |
TWI383796B (zh) * | 2009-08-14 | 2013-02-01 | Holy Stone Healthcare Co Ltd | Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer |
TWI516269B (zh) * | 2009-08-14 | 2016-01-11 | 禾伸堂生技股份有限公司 | 使用於炎症性腸疾病(ibd)治療和預防之透明質酸混合物 |
ES2362587B1 (es) * | 2009-12-24 | 2012-02-28 | Laboratorios Viñas S.A. | "toallita impregnada con una composición farmacéutica que comprende acido hialurónico, composición farmacéutica que comprende ácido hialurónico y usos correspondientes.". |
US8575130B2 (en) * | 2010-01-04 | 2013-11-05 | Holy Stone Healthcare Co., Ltd. | Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease |
US9114188B2 (en) * | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US20110171286A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan, Inc. | Hyaluronic acid compositions for dermatological use |
US20110172180A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
US20110171311A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
US20110171310A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
US8758221B2 (en) | 2010-02-24 | 2014-06-24 | Apollo Endosurgery, Inc. | Source reservoir with potential energy for remotely adjustable gastric banding system |
US8840541B2 (en) * | 2010-02-25 | 2014-09-23 | Apollo Endosurgery, Inc. | Pressure sensing gastric banding system |
WO2011109730A2 (fr) | 2010-03-04 | 2011-09-09 | The General Hospital Corporation | Procédés et systèmes de compensation des déficiences vocales au moyen d'un implant de muqueuse adaptable permettant de rétablir et renforcer la production sonore et vocale humaine individualisée |
EP2544652A2 (fr) | 2010-03-12 | 2013-01-16 | Allergan Industrie SAS | Composition fluide comprenant un polymère de hyaluronan et de mannitol pour l'amélioration d'états cutanés |
DK2550027T4 (da) | 2010-03-22 | 2019-05-13 | Allergan Inc | Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse |
US9044298B2 (en) | 2010-04-29 | 2015-06-02 | Apollo Endosurgery, Inc. | Self-adjusting gastric band |
US9028394B2 (en) | 2010-04-29 | 2015-05-12 | Apollo Endosurgery, Inc. | Self-adjusting mechanical gastric band |
US20110270024A1 (en) | 2010-04-29 | 2011-11-03 | Allergan, Inc. | Self-adjusting gastric band having various compliant components |
US20110270025A1 (en) | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Remotely powered remotely adjustable gastric band system |
US8517915B2 (en) | 2010-06-10 | 2013-08-27 | Allergan, Inc. | Remotely adjustable gastric banding system |
FR2962040B3 (fr) * | 2010-07-05 | 2012-08-10 | Alain Villette | Composition injectable comprenant un medicament injectable et un gel |
US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
US20120059216A1 (en) | 2010-09-07 | 2012-03-08 | Allergan, Inc. | Remotely adjustable gastric banding system |
IT1402382B1 (it) | 2010-09-09 | 2013-09-04 | Ibsa Inst Biochimique Sa | Complessi cooperativi ibridi di acido ialuronico |
EP2624874A4 (fr) | 2010-10-08 | 2014-04-02 | Univ Texas | Membrane de barrière antiadhésive utilisant de l'alginate et de l'acide hyaluronique pour des applications biomédicales |
WO2012048283A1 (fr) | 2010-10-08 | 2012-04-12 | Board Of Regents, The University Of Texas System | Traitement en une étape d'hydrogels pour obtenir des caractéristiques mécaniquement robustes et chimiquement souhaitables |
AU2015275313A1 (en) * | 2010-11-08 | 2016-01-21 | Allergan Industrie, Sas | Hyaluronic acid based formulations |
EP3138586B1 (fr) * | 2010-11-08 | 2021-01-06 | Allergan Industrie, SAS | Charges de tissus mous |
PL3138586T3 (pl) | 2010-11-08 | 2021-09-13 | Allergan Industrie, Sas | Wypełniacz tkanki miękkiej |
US8961393B2 (en) | 2010-11-15 | 2015-02-24 | Apollo Endosurgery, Inc. | Gastric band devices and drive systems |
FR2968305B1 (fr) | 2010-12-06 | 2014-02-28 | Teoxane | Procede de preparation d'un gel reticule |
KR102111170B1 (ko) | 2011-01-13 | 2020-05-15 | 알러간, 인코포레이티드 | 첨가제들을 포함하는 안정된 히드로겔 조성물들 |
EP2675491A2 (fr) | 2011-02-17 | 2013-12-25 | Allergan, Inc. | Compositions et procédés améliorés de remplacement de tissu mou |
US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
EP2714002B1 (fr) | 2011-06-03 | 2019-04-03 | Allergan, Inc. | Compositions de remplissage dermique comprenant des antioxydants |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
EP3590495A1 (fr) | 2011-08-25 | 2020-01-08 | Allergan, Inc. | Compositions de remplissage dermique comprenant des antioxydants |
US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
KR20200116168A (ko) | 2011-09-14 | 2020-10-08 | 알러간, 인코포레이티드 | 잔주름 치료를 위한 진피 필러 조성물 |
EP2581079B1 (fr) * | 2011-10-11 | 2016-12-07 | BioPolymer GmbH & Co. KG | Combinaison d'acide hyaluronique et de prilocaïne |
ITAN20110138A1 (it) | 2011-10-12 | 2012-01-11 | Regenyal Lab S R L | Sintesi di un gel iniettabile multifasico a base di acido ialuronico monofasico libero e reticolato e di acido ialuronico bifasico associato con idrossiapatite con inibitore della ialuronidasi microincapsulato. |
US8876694B2 (en) | 2011-12-07 | 2014-11-04 | Apollo Endosurgery, Inc. | Tube connector with a guiding tip |
KR102168028B1 (ko) | 2011-12-08 | 2020-10-20 | 알러간 인더스트리 에스에이에스 | 진피 필러 조성물 |
US8961394B2 (en) | 2011-12-20 | 2015-02-24 | Apollo Endosurgery, Inc. | Self-sealing fluid joint for use with a gastric band |
FR2991876B1 (fr) | 2012-06-13 | 2014-11-21 | Vivacy Lab | Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate |
CN104395348B (zh) * | 2012-06-15 | 2019-07-30 | 莫茨药物股份两合公司 | 制备基于透明质酸的组合物的方法 |
RU2015105317A (ru) | 2012-07-18 | 2016-09-10 | Аллерган Эндюстри, Сас | Композиция гиалуроновой кислоты, содержащая пируват |
FR2994846B1 (fr) | 2012-08-29 | 2014-12-26 | Vivacy Lab | Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium |
CA2886115A1 (fr) | 2012-10-02 | 2014-04-10 | Allergan, Inc. | Hydrogels de comblement dermique comportant des complexes d'inclusion de vitamine a/cyclodextrine |
WO2014055895A1 (fr) | 2012-10-05 | 2014-04-10 | Allergan, Inc. | Dispositif injectable et méthode de modelage, d'augmentation ou de correction de traits faciaux tels que du menton |
KR101766679B1 (ko) | 2012-12-11 | 2017-08-09 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 유착 방지를 위한 히드로겔 막 |
US11565027B2 (en) | 2012-12-11 | 2023-01-31 | Board Of Regents, The University Of Texas System | Hydrogel membrane for adhesion prevention |
KR102033179B1 (ko) * | 2012-12-28 | 2019-10-16 | 롯데정밀화학 주식회사 | 스킴코트 모르타르용 첨가제 및 이를 포함하는 스킴코트 모르타르 조성물 |
FR3006689A1 (fr) | 2013-06-11 | 2014-12-12 | Benedicte Vincente Tauzin | Procede de reticulation de l'acide hyaluronique; procede de preparation d'un hydrogel injectable; hydrogel obtenu; utilisation de l'hydroget obtenu |
PT3019177T (pt) | 2013-07-10 | 2020-12-30 | Matrix Biology Inst | Composições de hialuronano de elevada elasticidade e suas utilizações |
US9155757B2 (en) | 2013-10-07 | 2015-10-13 | Laboratoires Vivacy | Methods and kits for treating vaginal and vulvar vestibule mucosa disorders |
FR3015290B1 (fr) | 2013-12-23 | 2017-01-13 | Lab Vivacy | Compositions d'acide hyaluronique compreant de la mepivacaine |
CN106413766A (zh) | 2014-04-01 | 2017-02-15 | 克洛克斯科技公司 | 组织填料组合物及使用方法 |
AR099900A1 (es) | 2014-04-01 | 2016-08-24 | Merz Pharma Gmbh & Co Kgaa | Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso |
EP3200838B1 (fr) | 2014-09-30 | 2019-09-18 | Allergan Industrie, SAS | Compositions d'hydrogel stables pourvues d'additifs |
FR3029928B1 (fr) | 2014-12-15 | 2018-03-09 | Teoxane | Gel reticule |
WO2016123352A1 (fr) | 2015-01-28 | 2016-08-04 | Allergan, Inc. | Formulations pour coussinet adipeux articulaire, et procédés d'utilisation de celles-ci |
WO2016128783A1 (fr) * | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions et méthodes pour améliorer l'apparence de la peau |
RU2715234C2 (ru) | 2015-02-13 | 2020-02-26 | Аллерган Эндюстри, Сас | Имплантаты для моделирования, увеличения или коррекции частей лица, например подбородка |
FR3036035B1 (fr) | 2015-05-11 | 2018-10-05 | Laboratoires Vivacy | Compositions comprenant au moins un polyol et au moins un anesthesique |
US10004824B2 (en) | 2015-05-11 | 2018-06-26 | Laboratoires Vivacy | Compositions comprising at least one polyol and at least one anesthetic |
FR3037797B1 (fr) | 2015-06-24 | 2018-08-17 | Kylane Laboratoires Sa | Procede de preparation d'un hydrogel reticule injectable; hydrogel obtenu; utilisation de l'hydrogel obtenu |
US9737395B2 (en) | 2015-06-26 | 2017-08-22 | Phi Nguyen | Systems and methods for reducing scarring |
WO2017001056A1 (fr) * | 2015-06-30 | 2017-01-05 | Merz Pharma Gmbh & Co. Kgaa | Procédé de production d'acide hyaluronique réticulé |
US10130578B2 (en) | 2015-07-23 | 2018-11-20 | Johnson & Johnson Consumer Inc. | Topical delivery of skin compositions having low pH |
WO2017016917A1 (fr) | 2015-07-27 | 2017-02-02 | Galderma Sa | Procédé de réticulation efficace d'acide hyaluronique |
RU2727809C2 (ru) | 2015-09-24 | 2020-07-24 | Матрикс Байолэджи Инститьют | Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения |
FR3044557B1 (fr) | 2015-12-07 | 2017-12-01 | Benedicte Vincente Gavard Molliard Tauzin | Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition |
WO2017102001A1 (fr) | 2015-12-16 | 2017-06-22 | Vplus International Sa | Composition d'acide hyaluronique pour injections peniennes |
KR20170090965A (ko) * | 2016-01-29 | 2017-08-08 | 한미약품 주식회사 | 복합 히알루론산 가교물 및 그 제조방법 |
FR3047666A1 (fr) | 2016-02-15 | 2017-08-18 | Benedicte Vincente Gavard Molliard Tauzin | Composition injectable; procede de preparation de ladite composition; utilisation de ladite composition |
IT201600079633A1 (it) | 2016-07-28 | 2018-01-28 | Fidia Farm Spa | Procedimento di preparazione e purificazione del sale sodico dell’acido ialuronico |
KR20190070343A (ko) | 2016-10-13 | 2019-06-20 | 알레간 인코포레이티드 | 피부 필러 응용을 위한 코아세르베이트 하이알루로난 하이드로겔 |
FR3058064B1 (fr) | 2016-10-28 | 2020-08-07 | Lab Vivacy | Composition a base d'acide hyaluronique comprenant de la mepivacaine |
US10660419B2 (en) * | 2016-12-15 | 2020-05-26 | Elc Management Llc | Packaged skin treatment composition and method |
CN108250462A (zh) * | 2017-05-08 | 2018-07-06 | 上海利康瑞生物工程有限公司 | 一种抗酶解交联透明质酸钠凝胶及其制备方法和制剂 |
WO2018220283A1 (fr) | 2017-05-29 | 2018-12-06 | Kh Medtech Sarl | Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine |
JP6912327B2 (ja) | 2017-09-04 | 2021-08-04 | 大日精化工業株式会社 | 医療用・美容材料の製造方法及び医療用・美容材料 |
CN107802597B (zh) * | 2017-12-08 | 2020-07-31 | 北京诺康达医药科技股份有限公司 | 一种玻璃酸钠组合物及其制备方法和应用 |
WO2019217767A1 (fr) | 2018-05-09 | 2019-11-14 | The Johns Hopkins University | Composites de nanofibres-hydrogel pour le remplacement et la régénération améliorés de tissus mous |
EP3790602A1 (fr) | 2018-05-09 | 2021-03-17 | The Johns Hopkins University | Composites nanofibres-hydrogel pour l'administration de cellules et de tissus |
BR112021001515A2 (pt) | 2018-08-07 | 2021-04-27 | Merz Pharma Gmbh & Co. Kgaa | método para filtração dinâmica de um hidrogel reticulado |
IT201900021693A1 (it) * | 2019-11-20 | 2021-05-20 | Bmg Pharma S P A | Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione |
FR3111903B1 (fr) | 2020-06-24 | 2022-12-02 | Lab Vivacy | Procede d’incorporation de composes organiques en solution au sein d’un hydrogel |
KR102430642B1 (ko) * | 2020-07-03 | 2022-08-16 | 주식회사 메피온 | 필러 조성물 및 그 제조 방법 |
FR3113522A1 (fr) | 2020-08-20 | 2022-02-25 | Laboratoires Vivacy | procédé d’évaluation des caractéristiques rhéologiques d’un gel |
CN112940304B (zh) * | 2021-03-16 | 2023-02-28 | 杭州基智生物科技有限公司 | 一种三维细胞培养支架、成纤维细胞凝胶及其制备方法 |
TW202333793A (zh) * | 2022-01-11 | 2023-09-01 | 義大利商Gpq有限公司 | 作為創新填充劑之新玻尿酸衍生物 |
CN114409929A (zh) * | 2022-02-07 | 2022-04-29 | 南京易亨制药有限公司 | 一种聚合物水凝胶及其制备方法和其应用 |
FR3135399A1 (fr) | 2022-03-30 | 2023-11-17 | Laboratoires Vivacy | émulsion comprenant un hydrogel et de la graisse ou un dérivé de graisse |
CN116082713B (zh) * | 2022-12-06 | 2024-03-01 | 浙江工业大学 | 一种pH/温度双重响应智能水凝胶及其制备方法 |
Family Cites Families (214)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2128827A (en) * | 1938-03-09 | 1938-08-30 | Frank B Killian | Method and apparatus for manufacturing thin rubber articles |
CA807629A (en) * | 1966-06-30 | 1969-03-04 | Eigen Edward | Lotion and detergent compositions |
JPS4838158B1 (fr) * | 1970-10-05 | 1973-11-15 | ||
CA949965A (en) * | 1971-12-03 | 1974-06-25 | Robert H. Marchessault | Method of preparing cross-linked starch and starch derivatives |
US3949073A (en) * | 1974-11-18 | 1976-04-06 | The Board Of Trustees Of Leland Stanford Junior University | Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution |
US4060081A (en) * | 1975-07-15 | 1977-11-29 | Massachusetts Institute Of Technology | Multilayer membrane useful as synthetic skin |
CA1073360A (fr) * | 1975-10-22 | 1980-03-11 | John R. Daniels | Collagene non antigenique et articles fabriques avec ce collagene |
US4233360A (en) * | 1975-10-22 | 1980-11-11 | Collagen Corporation | Non-antigenic collagen and articles of manufacture |
JPS55153711A (en) | 1979-05-19 | 1980-11-29 | Pola Chem Ind Inc | Cosmetic lotion |
US4279812A (en) * | 1979-09-12 | 1981-07-21 | Seton Company | Process for preparing macromolecular biologically active collagen |
JPS6052129B2 (ja) * | 1979-10-04 | 1985-11-18 | 呉羽化学工業株式会社 | 医療用コラ−ゲン繊維の製造法 |
US4424208A (en) | 1982-01-11 | 1984-01-03 | Collagen Corporation | Collagen implant material and method for augmenting soft tissue |
US4582640A (en) | 1982-03-08 | 1986-04-15 | Collagen Corporation | Injectable cross-linked collagen implant material |
US4501306A (en) * | 1982-11-09 | 1985-02-26 | Collagen Corporation | Automatic syringe filling system |
SE442820B (sv) * | 1984-06-08 | 1986-02-03 | Pharmacia Ab | Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut |
SE456346B (sv) * | 1984-07-23 | 1988-09-26 | Pharmacia Ab | Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning |
US4636524A (en) * | 1984-12-06 | 1987-01-13 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
US4582865A (en) * | 1984-12-06 | 1986-04-15 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
US4605691A (en) * | 1984-12-06 | 1986-08-12 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
SE8501022L (sv) | 1985-03-01 | 1986-09-02 | Pharmacia Ab | Format alster och forfarande for dess framstellning |
US4713448A (en) | 1985-03-12 | 1987-12-15 | Biomatrix, Inc. | Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues |
US4642117A (en) * | 1985-03-22 | 1987-02-10 | Collagen Corporation | Mechanically sheared collagen implant material and method |
US4803075A (en) | 1986-06-25 | 1989-02-07 | Collagen Corporation | Injectable implant composition having improved intrudability |
FR2608456B1 (fr) | 1986-12-18 | 1993-06-18 | Mero Rousselot Satia | Microcapsules a base de gelatine et de polysaccharides et leur procede d'obtention |
US5385938B1 (en) | 1986-12-23 | 1997-07-15 | Tristrata Inc | Method of using glycolic acid for treating wrinkles |
US5091171B2 (en) | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
FR2623167B2 (fr) | 1987-08-14 | 1992-08-07 | Genus Int | Perfectionnement aux articles munis d'articulations elastiques se rigidifiant lors de leur mise en tension |
US5017229A (en) | 1990-06-25 | 1991-05-21 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
US6174999B1 (en) | 1987-09-18 | 2001-01-16 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
IT1219587B (it) * | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
US5614587A (en) | 1988-11-21 | 1997-03-25 | Collagen Corporation | Collagen-based bioadhesive compositions |
US5565519A (en) | 1988-11-21 | 1996-10-15 | Collagen Corporation | Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications |
US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5643464A (en) | 1988-11-21 | 1997-07-01 | Collagen Corporation | Process for preparing a sterile, dry crosslinking agent |
SE462587B (sv) | 1988-11-30 | 1990-07-23 | Wiklund Henry & Co | Anordning vid maerkning av arbetsstycken med skrift- eller andra tecken |
JPH02215707A (ja) | 1989-02-15 | 1990-08-28 | Chisso Corp | 皮膚化粧料 |
ES2075148T3 (es) | 1989-05-19 | 1995-10-01 | Hayashibara Biochem Lab | Acido alfa-glicosil-l-ascorbico, y su preparacion y usos. |
US5356883A (en) | 1989-08-01 | 1994-10-18 | Research Foundation Of State University Of N.Y. | Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
EP0416250A3 (en) | 1989-08-01 | 1991-08-28 | The Research Foundation Of State University Of New York | N-acylurea and o-acylisourea derivatives of hyaluronic acid |
CA2023922A1 (fr) | 1989-09-05 | 1991-03-06 | James M. Curtis | Methode de fabrication d'un article implantable avec une surface a micropillier |
JP2832848B2 (ja) | 1989-10-21 | 1998-12-09 | 株式会社林原生物化学研究所 | 結晶2―O―α―D―グルコピラノシル―L―アスコルビン酸とその製造方法並びに用途 |
US4996787A (en) * | 1990-05-29 | 1991-03-05 | Jack N. Holcomb | SigSauer pistol with concealed radio transmitter |
US5246698A (en) | 1990-07-09 | 1993-09-21 | Biomatrix, Inc. | Biocompatible viscoelastic gel slurries, their preparation and use |
US5143724A (en) | 1990-07-09 | 1992-09-01 | Biomatrix, Inc. | Biocompatible viscoelastic gel slurries, their preparation and use |
US5492936A (en) | 1990-11-30 | 1996-02-20 | Allergan, Inc. | Bimodal molecular weight hyaluronate formulations and methods for using same |
JP3115625B2 (ja) | 1991-03-30 | 2000-12-11 | 帝國製薬株式会社 | リドカイン含有外用貼付剤 |
US5314874A (en) | 1991-04-19 | 1994-05-24 | Koken Co., Ltd. | Intracorporeally injectable composition for implanting highly concentrated cross-linked atelocollagen |
JP3267972B2 (ja) | 1992-02-28 | 2002-03-25 | コラーゲン コーポレイション | 高濃度均質化コラーゲン組成物 |
IT1260154B (it) | 1992-07-03 | 1996-03-28 | Lanfranco Callegaro | Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn) |
CZ186995A3 (en) | 1993-01-20 | 1996-01-17 | Squibb & Sons Inc | Fibers |
CA2158638C (fr) | 1993-03-19 | 1999-11-30 | Bengt Agerup | Composition et methode d'augmentation tissulaire |
US5531716A (en) * | 1993-09-29 | 1996-07-02 | Hercules Incorporated | Medical devices subject to triggered disintegration |
US5616568A (en) | 1993-11-30 | 1997-04-01 | The Research Foundation Of State University Of New York | Functionalized derivatives of hyaluronic acid |
CA2146090C (fr) | 1994-05-10 | 1998-11-24 | Mark E. Mitchell | Appareil et methode de preparation de produits dans un environnement sterile |
US5482865A (en) * | 1994-06-10 | 1996-01-09 | Associated Universities, Inc. | Apparatus and method for preparing oxygen-15 labeled water H2 [15 O] in an injectable form for use in positron emission tomography |
US5616689A (en) | 1994-07-13 | 1997-04-01 | Collagen Corporation | Method of controlling structure stability of collagen fibers produced form solutions or dispersions treated with sodium hydroxide for infectious agent deactivation |
AU706434B2 (en) | 1994-10-18 | 1999-06-17 | Ethicon Inc. | Injectable liquid copolymers for soft tissue repair and augmentation |
US20050186673A1 (en) | 1995-02-22 | 2005-08-25 | Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie | Collagen carrier of therapeutic genetic material, and method |
FR2733427B1 (fr) | 1995-04-25 | 2001-05-25 | W K Et Associes | Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique |
FR2733426B1 (fr) | 1995-04-25 | 1997-07-18 | Debacker Yves | Dispositif medical pour le comblement des deformations du volume de la peau telles que rides et cicatrices par injection de 2 formes physico-chimiques differentes d'un polymere biologique |
US6214331B1 (en) | 1995-06-06 | 2001-04-10 | C. R. Bard, Inc. | Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained |
US5827937A (en) | 1995-07-17 | 1998-10-27 | Q Med Ab | Polysaccharide gel composition |
US5571503A (en) | 1995-08-01 | 1996-11-05 | Mausner; Jack | Anti-pollution cosmetic composition |
US6063405A (en) | 1995-09-29 | 2000-05-16 | L.A.M. Pharmaceuticals, Llc | Sustained release delivery system |
US6833408B2 (en) | 1995-12-18 | 2004-12-21 | Cohesion Technologies, Inc. | Methods for tissue repair using adhesive materials |
IT1277707B1 (it) | 1995-12-22 | 1997-11-11 | Chemedica Sa | Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare |
US5980948A (en) | 1996-08-16 | 1999-11-09 | Osteotech, Inc. | Polyetherester copolymers as drug delivery matrices |
US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
IT1287967B1 (it) | 1996-10-17 | 1998-09-10 | Fidia Spa In Amministrazione S | Preparazioni farmaceutiche per uso anestetico locale |
FR2759576B1 (fr) * | 1997-02-17 | 1999-08-06 | Corneal Ind | Implant de sclero-keratectomie pre-descemetique |
FR2759577B1 (fr) | 1997-02-17 | 1999-08-06 | Corneal Ind | Implant de sclerectomie profonde |
US5935164A (en) | 1997-02-25 | 1999-08-10 | Pmt Corporaton | Laminated prosthesis and method of manufacture |
FR2764514B1 (fr) | 1997-06-13 | 1999-09-03 | Biopharmex Holding Sa | Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique |
US7192984B2 (en) | 1997-06-17 | 2007-03-20 | Fziomed, Inc. | Compositions of polyacids and polyethers and methods for their use as dermal fillers |
US6391336B1 (en) | 1997-09-22 | 2002-05-21 | Royer Biomedical, Inc. | Inorganic-polymer complexes for the controlled release of compounds including medicinals |
FR2780730B1 (fr) | 1998-07-01 | 2000-10-13 | Corneal Ind | Compositions biphasiques injectables, notamment utiles en chirurgies reparatrice et esthetique |
US6630457B1 (en) * | 1998-09-18 | 2003-10-07 | Orthogene Llc | Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
IT1303738B1 (it) * | 1998-11-11 | 2001-02-23 | Aquisitio S P A | Processo di reticolazione di polisaccaridi carbossilati. |
DK172900B1 (da) | 1998-12-18 | 1999-09-27 | Per Julius Nielsen | Præparat samt kit til brug ved intraoculære operationer |
GB9902652D0 (en) | 1999-02-05 | 1999-03-31 | Fermentech Med Ltd | Process |
US6767928B1 (en) | 1999-03-19 | 2004-07-27 | The Regents Of The University Of Michigan | Mineralization and biological modification of biomaterial surfaces |
US6372494B1 (en) | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
US6521223B1 (en) * | 2000-02-14 | 2003-02-18 | Genzyme Corporation | Single phase gels for the prevention of adhesions |
US6682760B2 (en) | 2000-04-18 | 2004-01-27 | Colbar R&D Ltd. | Cross-linked collagen matrices and methods for their preparation |
KR20010096388A (ko) | 2000-04-19 | 2001-11-07 | 진세훈 | 귀두확대성형재료 및 이 재료를 이용한 귀두의 확대시술방법 |
FR2811671B1 (fr) | 2000-07-17 | 2003-02-28 | Corneal Ind | Hydrogel de polymere(s), resistant a la biodegration, preparation et utilisation a titre de support de regeneration tissulaire |
FR2811996B1 (fr) | 2000-07-19 | 2003-08-08 | Corneal Ind | Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations |
DE60133744T2 (de) | 2000-07-28 | 2009-05-14 | Anika Therapeutics, Inc., Woburn | Bioabsorbierbare kompositmaterialien aus derivatisierter hyaluronsäure |
US6620196B1 (en) | 2000-08-30 | 2003-09-16 | Sdgi Holdings, Inc. | Intervertebral disc nucleus implants and methods |
US6773723B1 (en) | 2000-08-30 | 2004-08-10 | Depuy Acromed, Inc. | Collagen/polysaccharide bilayer matrix |
US6924273B2 (en) | 2000-10-03 | 2005-08-02 | Scott W. Pierce | Chondroprotective/restorative compositions and methods of use thereof |
JP2004510730A (ja) | 2000-10-06 | 2004-04-08 | ヤゴテック アーゲー | 非経口的投与可能な制御放出微粒子調製物 |
KR100375299B1 (ko) * | 2000-10-10 | 2003-03-10 | 주식회사 엘지생명과학 | 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법 |
JP2005513081A (ja) | 2000-12-13 | 2005-05-12 | パーデュー・リサーチ・ファウンデイション | 溶媒交換による薬剤のマイクロカプセル化 |
US6979440B2 (en) | 2001-01-29 | 2005-12-27 | Salvona, Llc | Compositions and method for targeted controlled delivery of active ingredients and sensory markers onto hair, skin, and fabric |
US7119062B1 (en) | 2001-02-23 | 2006-10-10 | Neucoll, Inc. | Methods and compositions for improved articular surgery using collagen |
US6586493B1 (en) | 2001-03-07 | 2003-07-01 | Arizona Board Of Regents Arizona State University | Polysaccharide-based hydrogels and pre-gel blends for the same |
TW574301B (en) * | 2001-05-02 | 2004-02-01 | Ind Tech Res Inst | Manufacturing method of epoxide crosslinked polysaccharides matrix |
US20050227936A1 (en) | 2001-05-18 | 2005-10-13 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA) |
ES2385030T3 (es) | 2001-06-29 | 2012-07-17 | Medgraft Microtech, Inc. | Implantes inyectables biodegradables y procedimientos relacionados con su fabricación y uso |
US6749841B2 (en) | 2001-07-26 | 2004-06-15 | Revlon Consumer Products Corporation | Stabilized aqueous acidic antiperspirant compositions and related methods |
JP4230135B2 (ja) | 2001-08-21 | 2009-02-25 | 独立行政法人科学技術振興機構 | 多官能性架橋剤によって架橋したグリコサミノグリカン−コラーゲン複合体の製造法 |
US20060189516A1 (en) | 2002-02-19 | 2006-08-24 | Industrial Technology Research Institute | Method for producing cross-linked hyaluronic acid-protein bio-composites |
JP3916516B2 (ja) | 2002-06-10 | 2007-05-16 | 独立行政法人科学技術振興機構 | 硬組織−軟組織界面再生用足場材料 |
US6780366B2 (en) | 2002-08-15 | 2004-08-24 | Mentor Corporation | Drip retainer |
KR100523953B1 (ko) | 2002-08-27 | 2005-10-25 | 주식회사 엘지생명과학 | 천연다당류와 히알루론산의 마이크로비드 및 이의 제조 방법 |
KR100507545B1 (ko) | 2002-09-03 | 2005-08-09 | 주식회사 엘지생명과학 | 히알루론산 유도체 및 그의 제조방법 |
US20040127932A1 (en) | 2002-09-12 | 2004-07-01 | Shah Tilak M. | Dip-molded polymeric medical devices with reverse thickness gradient, and method of making same |
DE10246340A1 (de) * | 2002-10-04 | 2004-04-29 | Wohlrab, David, Dr. | Kombinationspräparat aus Hyaluronsäure und mindestens einem Lokalanästhetikum und dessen Verwendung |
US20040101959A1 (en) * | 2002-11-21 | 2004-05-27 | Olga Marko | Treatment of tissue with undifferentiated mesenchymal cells |
EP1581270A2 (fr) | 2002-12-30 | 2005-10-05 | Angiotech International Ag | Endoprotheses contenant de la soie |
TWI251596B (en) | 2002-12-31 | 2006-03-21 | Ind Tech Res Inst | Method for producing a double-crosslinked hyaluronate material |
WO2004073759A1 (fr) | 2003-02-19 | 2004-09-02 | Aventis Pharmaceuticals Holdings Inc. | Composition et methode pour augmenter le tissu mou intradermique |
WO2004087007A2 (fr) * | 2003-03-25 | 2004-10-14 | Biocure, Inc. | Dispositif medical de fil en hydrogel |
FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
AU2003901834A0 (en) | 2003-04-17 | 2003-05-01 | Clearcoll Pty Ltd | Cross-linked polysaccharide compositions |
JP2004323453A (ja) | 2003-04-25 | 2004-11-18 | Chisso Corp | 分解性ゲル及びその製造法 |
KR100931551B1 (ko) | 2003-05-13 | 2009-12-14 | 미마스 한도타이 고교 가부시키가이샤 | 웨이퍼 디마운트 방법, 웨이퍼 디마운트 장치 및 웨이퍼디마운트 이송기 |
BRPI0413086A (pt) | 2003-07-30 | 2006-10-03 | Anteis Sa | matriz complexa, utilização da mesma, e processo de preparação de uma matriz biocompatìvel pouco biodegradável |
JP4511470B2 (ja) | 2003-10-29 | 2010-07-28 | 帝人株式会社 | ヒアルロン酸化合物、そのハイドロゲルおよび関節軟骨損傷治療用材料 |
JP2007513083A (ja) | 2003-11-10 | 2007-05-24 | アンジオテック インターナショナル アーゲー | 医療用移植片および繊維誘発剤 |
US20060141049A1 (en) | 2003-11-12 | 2006-06-29 | Allergan, Inc. | Triamcinolone compositions for intravitreal administration to treat ocular conditions |
US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
US20090148527A1 (en) | 2007-12-07 | 2009-06-11 | Robinson Michael R | Intraocular formulation |
US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
CA2536242A1 (fr) | 2003-11-20 | 2005-06-09 | Angiotech International Ag | Capteurs implantables et pompes implantables et agents anti-cicatrisation |
US8124120B2 (en) | 2003-12-22 | 2012-02-28 | Anika Therapeutics, Inc. | Crosslinked hyaluronic acid compositions for tissue augmentation |
AU2004312532B2 (en) | 2003-12-30 | 2010-05-20 | Genzyme Corporation | Cohesive gels form cross-linked hyaluronan and/or hylan, their preparation and use |
DE102004002001A1 (de) | 2004-01-14 | 2005-08-11 | Reinmüller, Johannes, Dr.med. | Mittel zur Behandlung von entzündlichen Erkrankungen |
JP2007519756A (ja) | 2004-01-30 | 2007-07-19 | アンジオテック インターナショナル アーゲー | 拘縮を治療するための組成物および方法 |
US20050226936A1 (en) | 2004-04-08 | 2005-10-13 | Q-Med Ab | Method of soft tissue augmentation |
US8288362B2 (en) | 2004-05-07 | 2012-10-16 | S.K. Pharmaceuticals, Inc. | Stabilized glycosaminoglycan preparations and related methods |
US20050281880A1 (en) | 2004-05-20 | 2005-12-22 | Wei Wang | Methods for making injectable polymer hydrogels |
WO2005113608A1 (fr) | 2004-05-20 | 2005-12-01 | Mentor Corporation | Méthode pour lier covalemment l’hyaluronan et le chitosan |
CN101027065A (zh) | 2004-06-15 | 2007-08-29 | 陈献 | 磷脂组合物及其制备和使用方法 |
EP1781305A2 (fr) | 2004-08-13 | 2007-05-09 | Angiotech International Ag | Compositions et methodes utilisant de l'acide hyaluronique |
US20060040895A1 (en) | 2004-08-19 | 2006-02-23 | Kipling Thacker | Aesthetic use of hyaluronan |
US7414021B2 (en) | 2004-10-01 | 2008-08-19 | Vincent Carmine Giampapa | Method and composition for restoration of age related tissue loss in the face or selected areas of the body |
KR100762928B1 (ko) | 2004-10-29 | 2007-10-04 | 재단법인서울대학교산학협력재단 | 견 피브로인 나노섬유로 이루어진 부직포 형태의 골조직유도 재생용 차폐막 및 그 제조방법 |
US20060105022A1 (en) * | 2004-11-15 | 2006-05-18 | Shiseido Co., Ltd. | Process for preparing crosslinked hyaluronic acid gel |
ES2636998T3 (es) * | 2004-11-24 | 2017-10-10 | Albumedix A/S | Método de reticulación de ácido hialurónico con divinil sulfona |
FR2878444B1 (fr) | 2004-11-30 | 2008-04-25 | Corneal Ind Soc Par Actions Si | Solutions viscoelastiques renfermant du hyaluronate de sodiu et de l'hydroxypropylmethylcellulose, preparation et utilisations |
WO2006067608A1 (fr) | 2004-12-22 | 2006-06-29 | Laboratoire Medidom S.A. | Formulations aqueuses a base de hyaluronate de sodium a usage parenteral |
WO2006122183A2 (fr) | 2005-05-10 | 2006-11-16 | Cytophil, Inc. | Hydrogels injectables et leurs procedes de fabrication et d'utilisation |
EP1726299A3 (fr) | 2005-05-27 | 2007-04-18 | StratoSphere Pharma AB | Noyaux et microcapsules pour l' administration parenterale et procédé pour leur fabrication |
US7491709B2 (en) * | 2005-07-01 | 2009-02-17 | Wayne Carey | Treatment with hyaluronic acid |
EP1932530A4 (fr) | 2005-08-11 | 2009-04-29 | Hayashibara Biochem Lab | Agent améliorant la production de collagène et utilisation de celui-ci |
JP4982718B2 (ja) | 2005-08-31 | 2012-07-25 | 株式会社林原 | 美肌用の経口摂取用組成物 |
AU2006299421B2 (en) | 2005-10-03 | 2013-01-31 | Mark A. Pinsky | Compositions and methods for improved skin care |
US20070202084A1 (en) | 2005-12-14 | 2007-08-30 | Anika Therapeutics, Inc. | Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects |
EP1968614A2 (fr) | 2005-12-14 | 2008-09-17 | Anika Therapeutics Inc. | Traitements de l'arthrite et d'autres troubles musculo-squelettiques avec de l'acide hyaluronique réticulé |
FR2894827B1 (fr) | 2005-12-21 | 2010-10-29 | Galderma Res & Dev | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation,et leurs utilisations |
FR2895907B1 (fr) | 2006-01-06 | 2012-06-01 | Anteis Sa | Gel viscoelastique a usage dermatologique |
US20070184087A1 (en) | 2006-02-06 | 2007-08-09 | Bioform Medical, Inc. | Polysaccharide compositions for use in tissue augmentation |
US20070212385A1 (en) | 2006-03-13 | 2007-09-13 | David Nathaniel E | Fluidic Tissue Augmentation Compositions and Methods |
EP2004252A2 (fr) | 2006-03-15 | 2008-12-24 | SurModics, Inc. | Dérivés hydrophobes de polysaccharides biodégradables et utilisations de ceux-ci |
FR2900575B1 (fr) | 2006-05-05 | 2008-10-17 | Anteis Sa | Gel biocompatible a liberation controlee, son procede de preparation et son utilisation |
WO2007136738A2 (fr) | 2006-05-19 | 2007-11-29 | Trustees Of Boston University | Nouveaux polymères hydrophiles utilisés en tant que gels et lubrifiants à usage médical |
US20070298005A1 (en) | 2006-06-22 | 2007-12-27 | Marie-Josee Thibault | Injectable composition for treatment of skin defects or deformations |
WO2008003321A2 (fr) * | 2006-07-07 | 2008-01-10 | Novozymes Biopolymer A/S | Compositions avec plusieurs fractions d'acide hyaluronique destinées à un usage cosmétique |
US20100035838A1 (en) | 2006-09-19 | 2010-02-11 | Geoffrey Kenneth Heber | Cross-linked polysaccharide gels |
FR2908415B1 (fr) | 2006-11-10 | 2009-01-23 | Abr Dev Sarl | Acide hyaluronique reticule et son procede de preparation |
JP5068984B2 (ja) | 2006-11-30 | 2012-11-07 | 株式会社ロイヤル | 陳列棚 |
FR2909560B1 (fr) | 2006-12-06 | 2012-12-28 | Fabre Pierre Dermo Cosmetique | Gel d'acide hyaluronique pour injection intradermique |
EP2121026B1 (fr) | 2006-12-11 | 2017-06-28 | CHIT2GEL Ltd. | Nouveaux mélanges injectables de chitosans formant des hydrogels |
KR100759091B1 (ko) | 2006-12-13 | 2007-09-17 | 조강선 | 피부 충전제 조성물 |
ES2391862T3 (es) | 2006-12-22 | 2012-11-30 | Croma-Pharma Gesellschaft M.B.H. | Uso de polisacaridos tiolados para el aumento de tejido |
US20080188416A1 (en) | 2007-02-05 | 2008-08-07 | Freedom-2, Inc. | Tissue fillers and methods of using the same |
WO2008098019A2 (fr) | 2007-02-05 | 2008-08-14 | Carbylan Biosurgery, Inc. | Formulations polymères utilisables pour la délivrance d'agents bioactifs |
US7776840B2 (en) | 2007-02-21 | 2010-08-17 | Cutanea Life Sciences, Inc. | Methods of use of biomaterial and injectable implant containing biomaterial |
US7939578B2 (en) | 2007-02-23 | 2011-05-10 | 3M Innovative Properties Company | Polymeric fibers and methods of making |
US8642067B2 (en) | 2007-04-02 | 2014-02-04 | Allergen, Inc. | Methods and compositions for intraocular administration to treat ocular conditions |
US11078262B2 (en) | 2007-04-30 | 2021-08-03 | Allergan, Inc. | High viscosity macromolecular compositions for treating ocular conditions |
WO2008148967A2 (fr) | 2007-05-11 | 2008-12-11 | Galderma Research & Development | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations |
WO2008139122A2 (fr) | 2007-05-11 | 2008-11-20 | Galderma Research & Development | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations |
CA2687983A1 (fr) | 2007-05-23 | 2008-12-04 | Allergan, Inc. | Particules d'acide hyaluronique revetues |
BRPI0811784A2 (pt) | 2007-05-23 | 2011-05-10 | Allergan Inc | colÁgeno reticulado e uso do mesmo |
WO2008157608A1 (fr) | 2007-06-18 | 2008-12-24 | Cartlix, Inc. | Echafaudages composites pour la régénération tissulaire |
CA2694700C (fr) | 2007-07-27 | 2015-04-14 | Humacyte, Inc. | Compositions et procedes pour une augmentation de tissu mou |
US8318695B2 (en) | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
FR2920000B1 (fr) | 2007-08-13 | 2010-01-29 | Oreal | Composition cosmetique ou pharmaceutique contenant de l'acide hyaluronique, et procede cosmetique pour diminuer les signes du vieilissement |
US8529897B2 (en) | 2007-08-16 | 2013-09-10 | Carnegie Mellon University | Inflammation-regulating compositions and methods |
KR100813224B1 (ko) | 2007-08-24 | 2008-03-13 | 한양대학교 산학협력단 | 단백질 약물전달용 온도 가역성 코아세르베이트 조합 겔 |
FR2920968B1 (fr) | 2007-09-14 | 2009-11-13 | Oreal | Procede cosmetique de traitement esthetique et/ou reparateur de la peau |
US8697044B2 (en) | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
US7910134B2 (en) | 2007-10-29 | 2011-03-22 | Ayman Boutros | Alloplastic injectable dermal filler and methods of use thereof |
US8394782B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
US8394784B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
US20090143348A1 (en) | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
FR2924615B1 (fr) | 2007-12-07 | 2010-01-22 | Vivacy Lab | Hydrogel cohesif biodegradable. |
US9161970B2 (en) | 2007-12-12 | 2015-10-20 | Allergan, Inc. | Dermal filler |
US20090169615A1 (en) | 2007-12-26 | 2009-07-02 | Pinsky Mark A | Collagen Formulations for Improved Skin Care |
US20090291986A1 (en) | 2008-05-22 | 2009-11-26 | Apostolos Pappas | Composition and method of treating facial skin defect |
US20090297632A1 (en) | 2008-06-02 | 2009-12-03 | Waugh Jacob M | Device, Methods and Compositions to Alter Light Interplay with Skin |
WO2010003797A1 (fr) | 2008-07-09 | 2010-01-14 | Novozymes Biopharma Dk A/S | Acide hyaluronique pour la cicatrisation cornéenne |
US8357795B2 (en) | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
ES2829971T3 (es) | 2008-09-02 | 2021-06-02 | Tautona Group Lp | Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos |
EP2341953B1 (fr) | 2008-09-04 | 2018-11-21 | The General Hospital Corporation | Hydrogels pour l'augmentation et la réparation des cordes vocales et de tissu mou |
GB0816496D0 (en) | 2008-09-10 | 2008-10-15 | Zhao Xiaobin | Hyaluronic acid cryogel |
WO2010038771A1 (fr) | 2008-09-30 | 2010-04-08 | 中外製薬株式会社 | Composition pharmaceutique stabilisée à la lumière |
US20100098794A1 (en) * | 2008-10-17 | 2010-04-22 | Armand Gerard | Topical anti-wrinkle and anti-aging moisturizing cream |
US20100111919A1 (en) | 2008-10-31 | 2010-05-06 | Tyco Healthcare Group Lp | Delayed gelation compositions and methods of use |
WO2010053918A1 (fr) | 2008-11-05 | 2010-05-14 | Hancock Jaffe Laboratories, Inc. | Composite contenant du collagène et de l'élastine en tant qu'expanseur dermique et agent de remplissage tissulaire |
FR2938187B1 (fr) | 2008-11-07 | 2012-08-17 | Anteis Sa | Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur |
DK2352488T3 (en) | 2008-11-07 | 2017-03-27 | Klox Tech Inc | OXIDATIVE PHOTO-ACTIVATED SKIN REFRESHING COMPOSITION INCLUDING HYALURONIC ACID, GLUCOSAMINE, OR ALLANTOIN |
ITRM20080636A1 (it) | 2008-11-28 | 2010-05-29 | Univ Palermo | Procedimento per la produzione di derivati funzionalizzati dell acido ialuronico e relativi idrogeli. |
US20100136070A1 (en) | 2008-12-03 | 2010-06-03 | Jakk Group, Inc. | Methods, devices, and compositions for dermal filling |
NO2236523T3 (fr) | 2009-03-30 | 2018-07-21 | ||
ES2621380T3 (es) | 2009-04-02 | 2017-07-03 | Allergan, Inc. | Hidrogeles con forma de cabello para aumento de tejidos blandos |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
KR20200116168A (ko) | 2011-09-14 | 2020-10-08 | 알러간, 인코포레이티드 | 잔주름 치료를 위한 진피 필러 조성물 |
US9898263B2 (en) | 2013-04-09 | 2018-02-20 | Level 3 Communications, Llc | System and method for resource-definition-oriented software generation and development |
-
2003
- 2003-04-10 FR FR0304444A patent/FR2861734B1/fr not_active Expired - Lifetime
-
2004
- 2004-04-08 JP JP2006505785A patent/JP4827727B2/ja not_active Expired - Lifetime
- 2004-04-08 EP EP04742458A patent/EP1611160A2/fr not_active Ceased
- 2004-04-08 CA CA2521961A patent/CA2521961C/fr not_active Expired - Lifetime
- 2004-04-08 EP EP20140200048 patent/EP2868669A1/fr not_active Withdrawn
- 2004-04-08 US US10/552,309 patent/US7741476B2/en active Active
- 2004-04-08 EP EP20100181594 patent/EP2289945B1/fr not_active Revoked
- 2004-04-08 BR BRPI0409762-9A patent/BRPI0409762B1/pt active IP Right Grant
- 2004-04-08 ES ES10181594.2T patent/ES2536564T3/es not_active Expired - Lifetime
- 2004-04-08 WO PCT/FR2004/000870 patent/WO2004092222A2/fr active Application Filing
-
2010
- 2010-05-18 US US12/782,488 patent/US8338388B2/en not_active Expired - Lifetime
-
2012
- 2012-08-03 US US13/566,767 patent/US8563532B2/en not_active Expired - Lifetime
-
2013
- 2013-09-12 US US14/024,916 patent/US9062130B2/en not_active Expired - Lifetime
-
2014
- 2014-11-06 US US14/535,220 patent/US20150065701A1/en not_active Abandoned
-
2016
- 2016-07-13 US US15/209,561 patent/US10080767B2/en not_active Expired - Lifetime
-
2018
- 2018-09-20 US US16/137,447 patent/US10653716B2/en not_active Expired - Lifetime
-
2020
- 2020-04-23 US US16/856,029 patent/US11045490B2/en not_active Expired - Lifetime
-
2021
- 2021-06-28 US US17/361,195 patent/US20210322460A1/en active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO2004092222A2 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9144631B2 (en) | 2003-01-27 | 2015-09-29 | Benedicte Asius | Ceramic-based injectable implants which are used to fill wrinkles, cutaneous depressions and scars, and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
US20190022130A1 (en) | 2019-01-24 |
BRPI0409762B1 (pt) | 2021-10-13 |
US20060194758A1 (en) | 2006-08-31 |
US20200246375A1 (en) | 2020-08-06 |
US8338388B2 (en) | 2012-12-25 |
JP4827727B2 (ja) | 2011-11-30 |
EP2289945B1 (fr) | 2015-03-04 |
FR2861734A1 (fr) | 2005-05-06 |
WO2004092222A3 (fr) | 2004-12-09 |
WO2004092222A2 (fr) | 2004-10-28 |
US10080767B2 (en) | 2018-09-25 |
US20150065701A1 (en) | 2015-03-05 |
BRPI0409762A (pt) | 2006-05-09 |
CA2521961A1 (fr) | 2004-10-28 |
FR2861734B1 (fr) | 2006-04-14 |
US9062130B2 (en) | 2015-06-23 |
ES2536564T3 (es) | 2015-05-26 |
US8563532B2 (en) | 2013-10-22 |
US10653716B2 (en) | 2020-05-19 |
EP2868669A1 (fr) | 2015-05-06 |
JP2006522851A (ja) | 2006-10-05 |
CA2521961C (fr) | 2013-07-23 |
US20100226988A1 (en) | 2010-09-09 |
EP2289945A1 (fr) | 2011-03-02 |
US11045490B2 (en) | 2021-06-29 |
US20160317571A1 (en) | 2016-11-03 |
US7741476B2 (en) | 2010-06-22 |
US20120295870A1 (en) | 2012-11-22 |
US20210322460A1 (en) | 2021-10-21 |
US20140011990A1 (en) | 2014-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004092222A2 (fr) | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus; | |
EP1303542B3 (fr) | Preparation d'acide hyaluronique reticule et de son hydrogel, les produits obtenus et leurs utilisations. | |
CN109734825B (zh) | 用于制造成形的交联的透明质酸产物的方法 | |
WO1996033751A1 (fr) | Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique | |
CA2708023A1 (fr) | Hydrogel cohesif monophasique biodegradable | |
FR2733427A1 (fr) | Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique | |
EP1091775A1 (fr) | Compositions biphasiques injectables, notamment utiles en chirurgies reparatrice et esthetique | |
FR2983483A1 (fr) | Procede de substitution et reticulation simultanees d'un polysaccharide via ses fonctions hydroxyles | |
JP2022527503A (ja) | 複数の形態のヒアルロン酸を含む注射可能で均質なゲルおよびその製造方法 | |
WO2020212615A1 (fr) | Procede de reticulation d'un polymere | |
JP2024509534A (ja) | ポリマーをベースとする植込み型又は注入型生成物及びそれらの調製方法 | |
FR3113522A1 (fr) | procédé d’évaluation des caractéristiques rhéologiques d’un gel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20051010 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL HR LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
RBV | Designated contracting states (corrected) |
Designated state(s): DE ES FR GB IT |
|
17Q | First examination report despatched |
Effective date: 20070416 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ALLERGAN INDUSTRIE |
|
APBK | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNE |
|
APBN | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2E |
|
APBR | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3E |
|
APAF | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNE |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
APBT | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9E |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20120511 |